Guangdong, China

Beimei Liang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hainan Hualon Pharmaceutical Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Beimei Liang. Retrieved from https://idiyas.com/inventor/beimei-liang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Beimei Liang: Innovator in Anti-Infection Compounds

Introduction

Beimei Liang is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-infection compounds. His work has the potential to impact the treatment of infections, showcasing his innovative spirit and dedication to improving healthcare.

Latest Patents

Beimei Liang holds a patent for an optically active compound of prulifloxacin for treating infections. This patent, which is represented by the formula (1), details an anti-infection levorotatory optically active compound (S-configuration) of prulifloxacin. The preparation method involves using levorotatory prulifloxacin as the raw material, with the reaction conducted in an organic solvent in the presence of alkaline materials. The reaction temperature ranges from -20°C to 60°C, and the reaction time can vary from 15 minutes to 24 hours. This innovative approach highlights his expertise in pharmaceutical chemistry.

Career Highlights

Beimei Liang is currently employed at Hainan Hualon Pharmaceutical Co., Ltd. His role at the company allows him to further explore and develop his ideas in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Beimei Liang has collaborated with notable colleagues, including Jun Ying and Feng Peng. These partnerships have likely contributed to his success and the advancement of his research projects.

Conclusion

Beimei Liang's work in developing anti-infection compounds demonstrates his commitment to innovation in the pharmaceutical industry. His patent for the optically active compound of prulifloxacin is a testament to his expertise and potential impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…